
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1055 | 1027 | 1074 | 1150 | 1434 | - |
Fund Return | 5.48% | 2.74% | 7.35% | 4.77% | 7.48% | - |
Place in category | 81 | 67 | 75 | 41 | 36 | - |
% in Category | 62 | 59 | 64 | 35 | 41 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.14B | 0.23 | 9.28 | 10.26 | ||
T. Rowe Price Capital AppreciationI | 29.53B | 0.26 | 9.42 | - | ||
T. Rowe Price Blue Chip Growth | 30.63B | -7.63 | 15.63 | 13.38 | ||
T. Rowe Price Blue Chip Growth I | 28.51B | -7.58 | 15.77 | - | ||
T. Rowe Price Instl Large Cap Growt | 21.31B | -6.60 | 15.83 | 14.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS International New Discovery R6 | 5.15B | 7.16 | 5.81 | 5.01 | ||
Fidelity Series International Sm C | 3.73B | 9.14 | 8.98 | 7.47 | ||
Artisan International Small Cap Ins | 2.75B | 3.56 | 3.04 | - | ||
Oppenheimer International Small-MiI | 1.94B | 8.15 | 1.75 | 6.45 | ||
T. Rowe Price International Discov | 1.84B | 5.43 | 4.60 | 6.34 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BAWAG | AT0000BAWAG2 | 2.41 | 105.200 | +1.15% | |
MercadoLibre | US58733R1023 | 2.00 | 2,584.92 | -0.06% | |
Spie | FR0012757854 | 1.80 | 43.34 | 0.00% | |
Redcare Pharmacy NV | NL0012044747 | 1.64 | 123.000 | +0.08% | |
flatexDEGIRO AG | DE000FTG1111 | 1.22 | 24.60 | -1.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review